Moore Capital Management »

Crescent Biopharma shares owned by Moore Capital Management

Quarter-by-quarter ownership of Crescent Biopharma (CBIO) shares owned by Moore Capital Management from 13F filings

Historical chart of Moore Capital Management investment in Crescent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Crescent Biopharma held by Moore Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crescent Biopharma by Moore Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $297k 25k 11.86

More positions owned by Moore Capital Management

Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Amazon (AMZN)
Bank of America Corporation (BAC)
Alphabet Cap Stk Cl A (GOOGL)
Ubs Group SHS (UBS)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Msci Emg Mkt Etf Call Option (EEM)
Ally Financial (ALLY)
Microsoft Corporation (MSFT)
Select Sector Spdr Tr State Street Fin Call Option (XLF)
Broadcom (AVGO)

View all positions for Moore Capital Management

Top funds holding Crescent Biopharma

FMR
BVF
Fairmount Funds Management
VR Adviser
Fcpm Iii Services B.v.
Vestal Point Capital
Opaleye Management
Tang Capital Management
ADAR1 Capital Management
Logos Global Management
Vanguard Group
Deep Track Capital
Perceptive Advisors
Boxer Capital Management
Rtw Investments

View all funds holding Crescent Biopharma